Lukas Hainz

Hims & Hers Health, the telehealth company known by its ticker HIMS, has unequivocally become one of Wall Street's most contentious "battleground" stocks, creating a deeply polarized investment landscape that pits staunch bulls against determined bears. The company’s remarkable growth trajectory

Imagine a healthcare system where hospital readmissions drop significantly, maternal health outcomes improve dramatically, and bureaucratic delays become a relic of the past—all powered by artificial intelligence. The U.S. Department of Health and Human Services (HHS) has rolled out a sweeping

I'm thrilled to be speaking with James Maitland, a renowned expert in robotics and IoT applications in medicine. With a deep passion for harnessing technology to revolutionize healthcare, James has been at the forefront of analyzing trends and innovations in the medtech industry. Today, we’ll

Imagine a world where healthcare is just a click away, where patients in remote areas receive expert care without stepping foot in a hospital, and clinicians manage packed schedules with ease through virtual platforms. This isn’t a distant dream but the reality of telehealth today. Yet, with this

Imagine a world where a cancer diagnosis doesn’t come with the added fear of delayed treatment due to a shortage of critical medical materials. In the United States, this scenario is all too real for countless patients relying on nuclear medicine for life-saving diagnostics and therapies. The

Imagine a remote village in Sub-Saharan Africa where a sudden fever outbreak goes unnoticed for weeks, silently spreading to neighboring communities because health workers rely on paper reports that take days to reach national authorities. This scenario, far too common across the continent,

Imagine a scenario where a $7 million piece of life-saving medical equipment, weighing a staggering 21 tons, needs to be carefully lowered into a mid-20th-century building during a major renovation, all while ensuring its protection from weather and unauthorized access for years to come. This was

Imagine a world where vascular implants don’t just act as temporary fixes but actually help the body heal itself, transforming into natural tissue over time. This vision is becoming reality thanks to Xeltis, a Netherlands-based medical technology innovator that recently secured an impressive €47.5

Imagine a hospital call center so swamped that one in three callers hangs up before ever speaking to someone, while those who wait endure minutes that feel like hours, all just to book a simple appointment. This was the reality for Tampa General Hospital (TGH), a leading not-for-profit academic

Imagine stepping into a new chapter of health management with GLP-1 receptor agonist therapy, a promising approach for tackling type 2 diabetes or weight issues, only to face unexpected risks due to unseen health conditions. This scenario is far too common for many patients who dive into treatment